Evaluation of qSOFA as a Predictor of Mortality Among ICU Patients With Positive Clinical Cultures-A Retrospective

Barry Kelly1, Johann Patlak1, Shahzad Shaefi1

  • 1The Department of Anesthesia, Critical Care and Pain Medicine at 1859Beth Israel Deaconess Medical Center, Boston, MA, USA.

Abstract

Insights

The quick-sequential organ failure assessment score (qSOFA) is not superior to the SOFA score for predicting mortality in critically ill patients with infections. However, qSOFA showed similar performance to SOFA in patients with bloodstream infections or meningitis.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Clinical Scoring Systems

Background:

  • The quick-sequential organ failure assessment (qSOFA) score is a tool used to assess the risk of death in patients with suspected infection.
  • The standard sequential organ failure assessment (SOFA) score is more comprehensive but requires laboratory data.
  • Comparing the discriminative value of qSOFA and SOFA in critically ill patients with confirmed infections is crucial for clinical practice.

Purpose of the Study:

  • To compare the discriminative ability of the qSOFA score versus the SOFA score in predicting in-hospital mortality.
  • To evaluate the performance of qSOFA in a specific subgroup of patients with pathogenic bacteremia or positive cerebrospinal fluid cultures.

Main Methods:

  • Retrospective cohort study conducted at an academic tertiary referral center.
  • Inclusion of hospitalized patients admitted to the intensive care unit (ICU) with a microbial pathogen isolated within 48 hours of admission.
  • Analysis of in-hospital mortality as the primary outcome, with subgroup analyses for specific infection types.

Main Results:

  • The qSOFA score (≥2) was present in 25.7% of the 11,415 analyzed patients with positive microbiology within 48 hours of ICU admission.
  • In-hospital mortality was 16.6% for patients with qSOFA ≥2.
  • The discriminative value of qSOFA was significantly worse than SOFA overall (0.73 vs 0.76; P = .0004), but similar in patients with pathogenic bacteremia or positive CSF cultures (0.75 vs 0.78; P = .17).

Conclusions:

  • The qSOFA score is not superior to the SOFA score in predicting in-hospital mortality in critically ill patients with positive clinical cultures within 48 hours of ICU admission.
  • qSOFA demonstrated reasonable calibration and discrimination for mortality in this population.
  • In patients with pathogenic bacteremia or positive CSF cultures, qSOFA performed similarly to SOFA in discriminating mortality risk.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
319
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
745
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
379
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
476
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
319